Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    editor, Harvey D. White.
    Contents:
    Advances in acute coronary syndrome management / Harvey White
    Etiology and overview / Ralph A.H. Stewart
    Biomarkers in acute coronary syndromes / Harvey D. White
    Clinical risk scores in ACS management : current and future directions / Derek P. Chew & Leong Lee
    Antithrombotic therapies / Paul A. Gurbel & Udaya S. Tantry
    Lipid-lowering therapy / Joel A. Lardizabal & Prakash C. Deedwania
    Antihypertensive therapies / Grégoire Wuerzner, Olivier Muller & Michel Burnier
    Interventional approaches to acute coronary syndromes / Neal S. Kleiman
    Noninvasive imaging in acute coronary syndromes / Govind Srinivasan & Joseph Selvanayagam
    Electrocardiography in acute coronary syndromes / Cheuk-Kit Wong & Harvey D. White
    Current guidelines for acute coronary syndromes / Michel E. Bertrand
    Index.
    Digital Access Future Med 2012
  • Article
    Schwartz A, Askenase PW, Gershon RK.
    J Immunol. 1978 Oct;121(4):1573-7.
    The onset, intensity, and duration of DTH reactions elicited in mice immunized with either SRBC or products of the major histocompatibility complex can be altered significantly by pretreatment with CY 1 to 2 days before immunization. Such drug pretreatment tends to augment low DTH responses caused by the use of too much antigen and to diminish many responses that are optimal. Thus, pretreatment with CY does not specifically eliminate suppressor cells. Our results are most consistent with the notion that the cellular targets of low doses of CY are positive and negative feedback regulatory cells, which may consist of one population with two effects or, more likely, two distinct cell populations.
    Digital Access Access Options